PMVP Stock Analysis: Buy, Sell, or Hold?
PMVP - PMV Pharmaceuticals, Inc
$1.16
-0.02 (-1.69%)
▼
5d:
-3.33%
30d:
-17.14%
90d:
-22.67%
HOLD
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When PMVP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PMVP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PMVP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PMVP is currently trading at $1.16, which is considered oversold relative to its 30-day fair value range of $1.23 to $1.41.
Technical Outlook: Technically, PMVP is in a strong uptrend. The price is currently testing key support at $1.15. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PMVP has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $4.33 (+273.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PMVP is in a strong uptrend. The price is currently testing key support at $1.15. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PMVP has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $4.33 (+273.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.23 -
$1.41
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 273.6% below Wall St target ($4.33)
Trading Range Analysis
30-Day Trading Range
$1.23 -
$1.41
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.15
Resistance Level
$1.32
Current Trend
Strong Uptrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.06
Wall Street Target
$4.33
(+273.6%)
Share & Embed Analysis
Last updated: June 03, 2026 7:58 PM ET
Data refreshes hourly during market hours. Next update: 8:58 PM
Data refreshes hourly during market hours. Next update: 8:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PMVP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 62 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 56 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$123 | 50 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 52 HOLD |
